People · Operator
Named in public records as an officer, director or promoter · active 2010–2013 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Paringenix Inc | — | Pharmaceuticals | Series A | $10.6M | $101.3M | 2010 |
Neil A. Flanzraich at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Neil A. Flanzraich on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher A. Kroeger | 1 | 4 |
| Todd C. Brady | 1 | 3 |
| Myles D. Greenberg | 1 | 3 |
| Stephen G. Marcus | 1 | 1 |
| Claude G. Bertrand | 1 | 1 |
| Christopher G. Martin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.